Clinitech Laboratory Limited (BOM:544220)
India · Delayed Price · Currency is INR 37.80
0.00 (0.00%)
At close: May 29, 2026
Clinitech Laboratory Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 4.18 | 3.95 | 3.71 | 6.13 | 5.13 |
Depreciation & Amortization | 5.1 | 4.5 | 4.34 | 4.46 | 3.81 |
Other Amortization | - | - | 0.06 | - | - |
Loss (Gain) From Sale of Assets | - | -0.68 | - | - | - |
Loss (Gain) From Sale of Investments | - | - | -0.11 | - | - |
Other Operating Activities | -1.26 | -0.86 | 0.63 | -0.88 | -0.91 |
Change in Accounts Receivable | -3.14 | -9.43 | -1.09 | -1.25 | 1.94 |
Change in Inventory | -2.02 | -2.45 | -1.43 | 0.15 | -0.67 |
Change in Accounts Payable | -2.71 | 2.82 | -0.53 | -1.19 | 0.59 |
Change in Other Net Operating Assets | -8.08 | -6.63 | -18.38 | 5.06 | -0.33 |
Operating Cash Flow | -7.93 | -8.79 | -12.81 | 12.47 | 9.56 |
Operating Cash Flow Growth | - | - | - | 30.46% | 154.12% |
Capital Expenditures | -8.26 | -11.65 | -12.07 | -2.8 | -15.14 |
Sale of Property, Plant & Equipment | 0.2 | 3.06 | - | - | - |
Investment in Securities | - | - | 19.6 | -18.82 | -0.49 |
Other Investing Activities | 1.23 | 1.3 | 0 | 15.09 | 0.97 |
Investing Cash Flow | -6.83 | -7.29 | 7.54 | -6.53 | -14.66 |
Short-Term Debt Issued | - | - | - | 2.18 | 4.72 |
Long-Term Debt Issued | 5.38 | - | - | - | - |
Total Debt Issued | 5.38 | - | - | 2.18 | 4.72 |
Short-Term Debt Repaid | - | -5.77 | -1.18 | - | - |
Long-Term Debt Repaid | - | -2.86 | -0.48 | -0.75 | -1.23 |
Total Debt Repaid | - | -8.63 | -1.66 | -0.75 | -1.23 |
Net Debt Issued (Repaid) | 5.38 | -8.63 | -1.66 | 1.43 | 3.49 |
Issuance of Common Stock | 0.08 | 48.88 | 6.84 | - | - |
Other Financing Activities | -0.33 | -0.43 | -0.72 | -0.57 | -0.56 |
Financing Cash Flow | 5.13 | 39.82 | 4.46 | 0.86 | 2.93 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - |
Net Cash Flow | -9.63 | 23.74 | -0.82 | 6.8 | -2.16 |
Free Cash Flow | -16.18 | -20.43 | -24.88 | 9.68 | -5.58 |
Free Cash Flow Margin | -16.72% | -24.81% | -38.86% | 15.24% | -8.73% |
Free Cash Flow Per Share | -7.09 | -9.82 | -15.88 | 6.45 | -3.72 |
Cash Interest Paid | - | 0.43 | 0.72 | 0.57 | 0.42 |
Cash Income Tax Paid | - | 1.6 | 1.44 | 3 | 2.09 |
Levered Free Cash Flow | -14.9 | -20.57 | -12.97 | 9.72 | -5.76 |
Unlevered Free Cash Flow | -14.47 | -20.3 | -12.52 | 10.09 | -5.5 |
Change in Working Capital | -15.95 | -15.69 | -21.43 | 2.77 | 1.53 |